Now Playing
Opinion|Videos|March 21, 2025
Limitations and Challenges in Skin Cancer Staging Systems
Author(s)David Cotter, MD, PhD
An expert discusses the patient demographics and clinical features used in traditional staging and risk classification of melanoma and squamous cell carcinoma (SCC), examining how staging systems from organizations like the American Joint Committee on Cancer (AJCC) and National Comprehensive Cancer Network (NCCN) align in risk classification, the challenges of relying solely on clinical features for prognosis, and the importance of accurate risk staging in guiding treatment decisions for these cancers.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Discuss the patient demographics and clinical features that are included in traditional staging and risk classification of melanoma and SCC.
- Do the different staging systems, such as ones used by AJCC and NCCN, generally agree with regard to risk classification? Discuss some of the challenges with basing prognosis strictly on clinical features.
- What is the importance of accurate risk staging? How do treatment guidelines for melanoma and SCC differ based on the patient’s risk profile?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
3
FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA
4
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
5